{
  "id": "6026ef9d1cb411341a0000d5",
  "type": "factoid",
  "question": "When did eptinezumab get its first FDA approval?",
  "ideal_answer": "In February 2020, eptinezumab was approved in the USA for the preventive treatment of migraine in adults.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/32266704"
  ],
  "snippets": [
    {
      "text": " In February 2020, eptinezumab was approved in the USA for the preventive treatment of migraine in adults.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In February 2020, eptinezumab was approved in the USA for the preventive treatment of migraine in adults.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "In February 2020"
}